The Late-Breaking Clinical Trial Abstract Submission site is now open.
Submission deadline is February 13, 2023 at 11:59PM ET.
Waiver of mandatory manuscript submission for publication in JTCVS may be requested at the time of submission. The requirement for manuscript submission to the JTCVS does not apply to Abstracts for the C. Walton Lillehei Resident Forum, posters, or case videos.
Abstract submissions can be submitted to the following submission types and categories:
- Adult Cardiac: Clinical and translational studies pertaining to the selection, treatment, and outcomes of patients with acquired cardiovascular conditions.
- Congenital: Clinical and translational studies pertaining to the selection, treatment, and outcomes of patients with congenital disorders of the heart, lungs, and great vessels.
- Thoracic Surgery: Clinical and translational studies pertaining to the selection, treatment, and outcomes of patients with benign and malignant conditions of the lungs, airways, mediastinum, diaphragm, and chest wall.
- Additional: Presentations on subjects, which the submitter is uncertain about the proper category such as surgical education and training, quality assurance, workforce issues or other broad programs that do not fit neatly into one of the other categories.